CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Grant or award General Counsel, Secretary acquired 102,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 102,000 shares (grant or award)
- 4 Grant or award CTO & SVP of CMC acquired 102,000 shares (grant or award)
- 4 Grant or award Director acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 180,000 shares (grant or award)
- 4 Grant or award Director acquired 17,000 shares (grant or award)
- 4 Grant or award Director acquired 17,000 shares (grant or award)
- 4 Grant or award Director acquired 17,000 shares (grant or award)
- 4 Shares withheld for taxes CTO & SVP of CMC gave up 4,599 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,431 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,146 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 1,562 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,431 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes General Counsel, Secretary gave up 64,158 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 21,000 shares at an average $1.27 ($26,750)
- 4 Open-market sale Director sold 2,000 shares at $1.32 ($2,640)
- 4 Open-market sale Chief Scientific Officer sold 5,250 shares at $1.40 ($7,367)
Page 4 of 13 · 246 filings